英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
whatchy查看　whatchy　在百度字典中的解释百度英翻中〔查看〕
whatchy查看　whatchy　在Google字典中的解释Google英翻中〔查看〕
whatchy查看　whatchy　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Home - Armata Pharmaceuticals
    Learn more about how Armata Pharmaceuticals is leading the fight against antibiotic resistance from Armata Pharmaceuticals, Inc on Vimeo
  • Careers - Armata Pharmaceuticals
    Armata Pharmaceuticals is a World Leader in Bacteriophage Science At Armata Pharmaceuticals, we have built a challenging and dynamic work environment that values talent, initiative, collaboration and commitment We are seeking passionate and dedicated individuals eager to join our scientific team to develop the next-generation of antimicrobial therapies based on harnessing the power of
  • Armata Pharmaceuticals Receives $4. 65 Million of Additional Non . . .
    LOS ANGELES, May 1, 2025 PRNewswire -- Armata Pharmaceuticals, Inc (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on the development of high-purity, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections, today announced that it has received an additional $4 65 million of non
  • Armata Pharmaceuticals Announces First Quarter 2026 Results and . . .
    About Armata Pharmaceuticals, Inc Armata is a late clinical-stage biotechnology company focused on the development of high-purity pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology
  • Pipeline Overview - Armata Pharmaceuticals
    Pipeline Overview Armata’s goal is to demonstrate the safety, tolerability and definitive efficacy of multiple therapeutic phage candidates in randomized controlled clinical trials required for regulatory approval and to support commercialization in both acute and chronic indications of high unmet medical need
  • Management - Armata Pharmaceuticals
    Peter leads Armata’s operations team with over 17 years of experience in biotech and pharmaceutical production with companies like Baxter Bioscience, GlaxoSmithKline, Pacira Pharmaceuticals and Kite Pharma
  • Company Overview - Armata Pharmaceuticals
    Armata Pharmaceuticals is a clinical-stage biotechnology company focused on the development of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections
  • Contact Us - Armata Pharmaceuticals
    Headquarters 5005 McConnell Ave Los Angeles, CA 90066 Tel: +1 (310) 665-2928 Fax: +1 (310) 665-2963 Email » Business Development Contact us to learn more about our technology and partnering opportunities Email » Investor Relations Armata: +1 (310) 594-7035 LifeSci Advisors: +1 (212) 915-2569 Email »
  • Synthetic Phage Platform - Armata Pharmaceuticals
    Armata is harnessing its proprietary synthetic phage platform to develop targeted therapeutics for the treatment of various multidrug-resistant bacterial infections
  • Publications - Armata Pharmaceuticals
    Bacteria-eating viruses could provide a route to stability in cystic fibrosis: Phage therapy is broadening the treatment landscape for people with drug-resistant infections





中文字典-英文字典  2005-2009